We can’t show the full text here under this license.
dHyperCas12a allows simultaneous CRISPR interference of multiple genes
Updated
Abstract
Essence
dHyperLbCas12a enables highly multiplexed activation and repression to test how regulatory elements combine to shape gene expression.
Evidence
This CRISPR platform study combined hyper-efficient with RNA Polymerase II long arrays and demonstrated activation, repression, simultaneous control, and combinatorial CRE perturbation in primary immune cells and induced pluripotent stem cell differentiation.
Caveat
The abstract reports tool performance and gene-expression perturbation in cellular systems, not organism-level or clinical outcomes.
Simplified
Key numbers
85%
Repression Rate
Repression of hexokinase domain containing 1 gene in HepG2 cells.
7×
Target Sites Increase
dEnAsCas12a recognizes several non-canonical sequences.
2500-fold
Multiplexed Activation Range
Effectiveness of dHyperLbCas12a-P300 in A549 cells.